DISEASE SCANNER
Global Incurable Diseases Tracker
Diphtheria
A serious bacterial infection causing thick gray membrane in throat and nose, breathing difficulty, heart damage, and nerve paralysis. Caused by Corynebacterium diphtheriae. Once major childhood killer, now rare in vaccinated populations. Vaccine-preventable.
50.0K
17
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Clinical diagnosis (gray membrane)
- 2Throat/nasal culture
- 3PCR testing
- 4Elek test (toxin detection)
- 5Gram stain
Prognosis
Guarded. 5-10% mortality with treatment; up to 50% without. Heart complications common. Neuropathy may develop weeks after recovery. Respiratory failure possible. Full recovery possible with prompt treatment.
Prevention
- DTaP vaccination (children)
- Tdap or Td boosters
- Treatment and vaccination of contacts
- Isolation of cases
- Travel vaccination
- Maintaining high vaccination coverage
Research Status
DTaP/Tdap vaccines highly effective. Diphtheria antitoxin (DAT) for treatment. Antibiotics (erythromycin/penicillin). Rare in developed countries due to vaccination. Outbreaks in under-vaccinated populations. Research minimal (current vaccines very effective).
Affected Countries
Sources
- https://www.cdc.gov/diphtheria
- https://www.who.int/news-room/fact-sheets/detail/diphtheria
- https://www.mayoclinic.org/diseases-conditions/diphtheria
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.